South Tyneside District General Hospital, Harton Lane, South Shields, Tyne and Wear, NE34 0PL, UK.
Expert Rev Gastroenterol Hepatol. 2013 Jul;7(5):421-37. doi: 10.1586/17474124.2013.811045.
The National Health Service Bowel Cancer Screening Program (NHS BCSP) was developed to improve outcomes from colorectal cancer, the third most frequent cancer and the second highest cause of cancer deaths in the UK. Screening pilot programs were developed after previous trials demonstrated a reduction in mortality with the use of fecal occult blood population screening. A successful pilot period led to the roll out of national biennial screening for all 60-69 year olds in 2006, and extended to 60-74 year olds in 2010. To the end of 2012, there have been over 16 million invitations to screening, with uptake of 55.35%. FOBt positivity was 2.08%. Almost 15,000 cancers have been identified; screen-detected cancers have been shown to be at an earlier stage than non-screen-detected, with 35% Dukes' stage A. The BCSP provides high quality colonoscopy with low adverse events rates. It is also a rich data source for research.
英国国家医疗服务体系(NHS)肠癌筛查计划(NHS BCSP)旨在改善英国第三大常见癌症和第二大癌症死亡原因——结直肠癌的治疗效果。在先前的试验表明粪便潜血人群筛查可降低死亡率后,开展了筛查试点项目。成功的试点阶段促使 2006 年开始为所有 60-69 岁的人群提供两年一次的全国性筛查,并于 2010 年扩大到 60-74 岁的人群。截至 2012 年底,已发出超过 1600 万份筛查邀请,参与率为 55.35%。FOBt 阳性率为 2.08%。已发现近 15000 例癌症;筛查发现的癌症比非筛查发现的癌症更早,其中 35%为 Dukes' 分期 A。BCSP 提供高质量的结肠镜检查,且不良反应发生率低。它也是一个丰富的研究数据来源。